PROTECT is a new synbiotic technology combining probiotics and prebiotics to prevent respiratory infections. It aims to restore healthy lung bacteria and block harmful pathogens like Pseudomonas aeruginosa. By promoting beneficial bacteria, PROTECT helps prevent harmful microbes from taking hold, spreading, or developing resistance. The project focuses on identifying the best bacteria-nutrient combinations to treat conditions like cystic fibrosis. A central goal is creating the Airway Systematic Microbial Atlas (ASMA), a database of strains and resources to support future scientific and medical research.
PROTECT is currently exploring several other airway-associated indications, and we are enthusiastic to speak with interested parties. To reach us, please use the “Contact Us” button found at the bottom of this page.
Research
The PROTECT platform focuses on developing a synbiotic therapy—combining beneficial bacteria and nutrients—to prevent lung infections by restoring healthy microbial communities, especially in people with cystic fibrosis and related respiratory conditions.
Team
The PROTECT team brings together experts in microbiology, bioengineering, computational biology and respiratory health, working collaboratively to advance innovative approaches to infection prevention.
ASMA
One key part of PROTECT is building an Airway Systematic Microbial Atlas (ASMA), a database that will store all the data and resources developed, such as bacterial strains, making this valuable information available to the broader scientific and medical communities for future research.
News
Stay up to date with the latest developments from PROTECT, including research milestones, publications, events, and media coverage.
PROTECT Dashboard
PROTECT at University of California Berkeley is supported by the The Advanced Research Projects Agency for Health (ARPA-H). More information can be found on their homepage.